Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PolyHeme. Northfield Laboratories.

Jonathon S Jahr1, Namrata Varma

  • 1David Geffen School of Medicine at UCLA, Department of Anesthesiology, Box 951778, Los Angeles, CA 90095, USA. jsjahr@mednet.ucla.edu

Idrugs : the Investigational Drugs Journal
|May 22, 2004
PubMed
Summary

Northfield is developing PolyHeme, a polymerized hemoglobin solution, as a potential blood substitute. This innovative approach aims to address needs in surgical and trauma care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolated Langerhans Cell Histiocytosis Bone Lesion in Pediatric Patients: Systematic Review and Treatment Algorithm.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2015
Same author

Surgical management outcomes of recurrent thyroglossal duct cyst in children--A systematic review.

International journal of pediatric otorhinolaryngology·2015
See all related articles

Area of Science:

  • Biomedical Engineering
  • Hematology

Background:

  • Blood transfusions are critical in managing surgical and trauma-related blood loss.
  • The demand for safe and effective blood substitutes remains high due to supply limitations and transfusion risks.

Purpose of the Study:

  • To introduce PolyHeme, a novel polymerized hemoglobin solution developed by Northfield.
  • To evaluate PolyHeme as a potential cell-free blood substitute for clinical applications.

Main Methods:

  • Polymerization of human hemoglobin to create a stable, oxygen-carrying solution.
  • Preclinical and clinical investigations into PolyHeme's efficacy and safety profile.

Main Results:

  • PolyHeme demonstrates oxygen-carrying capacity comparable to red blood cells.
  • Initial studies suggest potential for use in scenarios where traditional transfusions are not feasible.

Conclusions:

  • PolyHeme represents a promising advancement in the field of blood substitutes.
  • Further research and clinical trials are warranted to establish its role in transfusion medicine.

Related Experiment Videos